Congenica selected for final phase of Instand-NGS4P
Congenica has been selected for the third phase of a contract to develop standardised Next-Generation Sequencing (NGS) workflows in oncology.
Congenica and myTomorrows announce partnership to advance Precision Oncology by facilitating rapid access to clinical trials
Congenica and myTomorrows have partnered to expedite access to precision oncology for cancer patients worldwide.
The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology
Philip Beer presented a webinar exploring one of the key challenges that we are currently facing when applying genomic testing in cancer.
The time has come to change the way we treat cancer
Professor Andrew Biankin shares his experiences in transforming cancer care with genomic testing.
Congenica announces Early Access Program for its novel Precision Oncology Solution
Congenica launches early access program for its new CE-IVD Precision Oncology Solution
Collaborative development of novel Precision Oncology Solution
Congenica has selected the GenomOncology Precision Oncology Platform for the development of a novel ground-breaking CE-IVD Precision Oncology Solution.